PNV.AX
Price:
$2.08
Market Cap:
$1.44B
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.[Read more]
Industry
Medical - Devices
IPO Date
1998-11-30
Stock Exchange
ASX
Ticker
PNV.AX
According to PolyNovo Limited’s latest financial reports and current stock price. The company's current PE Ratio is 208.00. This represents a change of -1327.90% compared to the average of -16.94 of the last 4 quarters.
The mean historical PE Ratio of PolyNovo Limited over the last ten years is -193.69. The current 208.00 PE Ratio has changed -10838.98% with respect to the historical average. Over the past ten years (40 quarters), PNV.AX's PE Ratio was at its highest in in the June 2015 quarter at 225.00. The PE Ratio was at its lowest in in the June 2021 quarter at -436.88.
Average
-193.69
Median
-135.83
Minimum
-753.68
Maximum
305.69
Discovering the peaks and valleys of PolyNovo Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 459.02%
Maximum Annual PE Ratio = 305.69
Minimum Annual Increase = -241.90%
Minimum Annual PE Ratio = -753.68
Year | PE Ratio | Change |
---|---|---|
2024 | 305.69 | -241.90% |
2023 | -215.43 | -71.42% |
2022 | -753.68 | 86.14% |
2021 | -404.90 | 1.12% |
2020 | -400.40 | 27.38% |
2019 | -314.33 | 459.02% |
2018 | -56.23 | 138.61% |
2017 | -23.57 | -47.76% |
2016 | -45.11 | 55.98% |
2015 | -28.92 | 129.60% |
The current PE Ratio of PolyNovo Limited (PNV.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-221.14
5-year avg
-293.74
10-year avg
-193.69
PolyNovo Limited’s PE Ratio is greater than AVITA Medical, Inc. (-5.71), greater than Nanosonics Limited (72.64), less than Pro Medicus Limited (338.50), greater than EML Payments Limited (-35.75), greater than Megaport Limited (122.05),
Company | PE Ratio | Market cap |
---|---|---|
-5.71 | $380.10M | |
72.64 | $944.03M | |
338.50 | $28.05B | |
-35.75 | $304.40M | |
122.05 | $1.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PolyNovo Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PolyNovo Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PolyNovo Limited's PE Ratio?
How is the PE Ratio calculated for PolyNovo Limited (PNV.AX)?
What is the highest PE Ratio for PolyNovo Limited (PNV.AX)?
What is the 3-year average PE Ratio for PolyNovo Limited (PNV.AX)?
What is the 5-year average PE Ratio for PolyNovo Limited (PNV.AX)?
How does the current PE Ratio for PolyNovo Limited (PNV.AX) compare to its historical average?